
1. rev prat. 2011 jan;61(1):52-4.

[risk hbv reactivation chemotherapy immunosuppressants].

[article french]

belle a(1), bronowicki jp.

author information: 
(1)inserm 954, service d'hépato-gastroentérologie, chu de nancy, 54500
vandoeuvre-lès-nancy.


pmid: 21452543  [indexed medline]

